Tag: thrombosis

Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on long-term anticoagulation therapy, suggests a major registry analysis. There was no significant difference in adjusted risk of bleeding or in a primary endpoint that included death and ischemic events whether

Skip to: Stroke and its Pathways Biomarkers and Risk Scores What are the Benefits of Using Biomarkers? Stroke, a complication of atrial fibrillation, can be fatal. Identification of biomarkers to predict stroke may help treat those at highest risk. Given the association between atrial fibrillation and other poor disease outcomes, biomarker identification has applications for

COVID-19: blood thinners do not settle In scientific studies, it has shown a close connection between the Coronavirus SARS-CoV-2-induced disease COVID-19, and coagulation disorders. In addition, it was found that many patients who are severely Ill thrombosis and pulmonary embolism. Experts underline the fact that heart patients should not stop your blood thinners. A long

COVID-19-Ill: Increased Rate of thrombosis and pulmonary embolism COVID-19 results in an unusually high number of cases of disease to thrombosis and pulmonary embolism. This was shown by a study of scientists from Hamburg. The new findings could lead to changes in treatment recommendations for the Coronavirus fell Ill. A few days ago was published